Even though Mundipharma is a collection of independent associated companies, the network relies on companies providing shared services to take ideas for drugs through development, authorisation and then into the hands of doctors and their patients. For example, a medicine may be developed within a Mundipharma research company, and the regulatory function will seek drug authorisation in multiple territories. And finally a sales company will drive the distribution into markets and to educate local doctors and health care professionals about the benefits of the treatment.
With records dating back to the company’s inception, Mundipharma seeks to keep necessary and valuable technical data, rather than storing data arbitrarily or ‘just in case’. However, there is still the challenge that much of this data is unstructured, and therefore not easily searchable. Masses of company data, commercial information and scientific and technical information are all stored together, either in emails, the enterprise vault storage or hard drives.
In the past, this hasn’t presented much of an issue because the company has benefitted from a strong organisational memory – if you needed to find something you could just ask someone and they’d know where to look. But over time, people have left the company or retired, taking that knowledge with them, so locating the right data is getting harder, especially as the data set continues to grow.